These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8979420)

  • 21. Development of conventional subunit vaccines for anaplasmosis and babesiosis.
    Montenegro-James S; Johnson WC; Goff WL
    Vet Parasitol; 1995 Mar; 57(1-3):255-66. PubMed ID: 7597788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunisation of smallholder dairy cattle against anaplasmosis and babesiosis in Malawi.
    Tjornehoj K; Lawrence JA; Kafuwa PT; Whiteland AP; Chimera BA
    Trop Anim Health Prod; 1997 May; 29(2):77-82. PubMed ID: 9203307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a frozen trivalent attenuated vaccine against Babesiosis and anaplasmosis in Brazil.
    Vidotto O; Barbosa CS; Andrade GM; Machado RZ; da Rocha MA; Silva SS
    Ann N Y Acad Sci; 1998 Jun; 849():420-3. PubMed ID: 9668502
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of tetracycline and Babesia culture supernatant as prophylactics for moderating reactions in cattle to live Babesia and Anaplasma vaccines.
    Jorgensen WK; Bock RE; Kingston TG; de Vos AJ; Waldron SJ
    Aust Vet J; 1993 Jan; 70(1):35-6. PubMed ID: 8460988
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence, risk factors, and genetic diversity of veterinary important tick-borne pathogens in cattle from Rhipicephalus microplus-invaded and non-invaded areas of Benin.
    Adjou Moumouni PF; Aplogan GL; Katahira H; Gao Y; Guo H; Efstratiou A; Jirapattharasate C; Wang G; Liu M; Ringo AE; Umemiya-Shirafuji R; Suzuki H; Xuan X
    Ticks Tick Borne Dis; 2018 Mar; 9(3):450-464. PubMed ID: 29307783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-infection with tick-borne disease agents in cattle in Russia.
    Bursakov SA; Kovalchuk SN
    Ticks Tick Borne Dis; 2019 Apr; 10(3):709-713. PubMed ID: 30878569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overcoming constraints to meeting increased demand for Babesia bigemina vaccine in Australia.
    Standfast NF; Bock RE; Wiecek MM; deVos AJ; Jorgensen WK; Kingston TG
    Vet Parasitol; 2003 Jul; 115(3):213-22. PubMed ID: 12935736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential for recombinant Babesia bovis antigens to protect against a highly virulent isolate.
    Hope M; Riding G; Menzies M; Colditz I; Reverter A; Willadsen P
    Parasite Immunol; 2005 Dec; 27(12):439-45. PubMed ID: 16255742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tick-borne diseases of cattle in Paraguay. II. Immunisation against anaplasmosis and babesiosis.
    Payne RC; Osorio O; Ybañez A
    Trop Anim Health Prod; 1990 May; 22(2):101-8. PubMed ID: 2196724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospects for recombinant vaccines against Babesia bovis and related parasites.
    Brown WC; Norimine J; Goff WL; Suarez CE; McElwain TF
    Parasite Immunol; 2006 Jul; 28(7):315-27. PubMed ID: 16842268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-thawing viability of vaccines for bovine babesiosis and anaplasmosis cryopreserved with glycerol.
    Mangold AJ; Aguirre DH; Guglielmone AA
    Vet Parasitol; 1990 Nov; 37(3-4):301-6. PubMed ID: 2267730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuated vaccines for animal diseases.
    Seitzer U; Ahmed J
    Vaccine; 2008 Dec; 26 Suppl 6():G1-3. PubMed ID: 19178885
    [No Abstract]   [Full Text] [Related]  

  • 33. Live vaccines against bovine babesiosis.
    de Waal DT; Combrink MP
    Vet Parasitol; 2006 May; 138(1-2):88-96. PubMed ID: 16504404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of a reverse line blot assay to the study of haemoparasites in cattle in Uganda.
    Oura CA; Bishop RP; Wampande EM; Lubega GW; Tait A
    Int J Parasitol; 2004 Apr; 34(5):603-13. PubMed ID: 15064125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for the control of one-host ticks and relationship with tick-borne diseases in South America.
    Nari A
    Vet Parasitol; 1995 Mar; 57(1-3):153-65. PubMed ID: 7597780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The development of a recombinant Babesia vaccine.
    Wright IG; Casu R; Commins MA; Dalrymple BP; Gale KR; Goodger BV; Riddles PW; Waltisbuhl DJ; Abetz I; Berrie DA
    Vet Parasitol; 1992 Sep; 44(1-2):3-13. PubMed ID: 1441189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serological evidence of exposure to tick fever organisms in young cattle on Queensland dairy farms.
    Sserugga JN; Jonsson NN; Bock RE; More SJ
    Aust Vet J; 2003 Mar; 81(3):147-52. PubMed ID: 15080428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conventional vaccines for tick-borne haemoparasitic diseases of sheep and goats.
    Lawrence JA
    Parassitologia; 1997 Jun; 39(2):119-21. PubMed ID: 9530695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features associated with seroconversion to Anaplasma marginale, Babesia bigemina and Theileria parva infections in African cattle under natural tick challenge.
    Magona JW; Walubengo J; Olaho-Mukani W; Jonsson NN; Welburn SC; Eisler MC
    Vet Parasitol; 2008 Aug; 155(3-4):273-80. PubMed ID: 18579313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Australian frozen vaccines for the control of babesiosis and anaplasmosis in cattle--a review.
    Dalgliesh RJ; Jorgensen WK; de Vos AJ
    Trop Anim Health Prod; 1990 Feb; 22(1):44-52. PubMed ID: 2181745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.